PLSM PLSM
Company Profile ↓Company Overview
PLSM (PLSM) is a publicly traded company listed on with a market capitalization of $23.02M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 54.7% CAGR over the past five years.
Recent Developments
- Dec 2025 Revenue of $40.02M (+314.3% YoY); net profit $-15.85M.
- Trailing 12 Months Year-on-year growth — revenue +314.3%.
- 5-Year Trend Long-term compounding — revenue CAGR 54.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 54.68% |
| 1 Year: | 314.28% |
Stock Price Performance
| 1 Year: | -51.90% |
| 6 Months: | -41.97% |
| 3 Months: | +4.73% |
| 1 Month: | -23.04% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- RSI (14)44.92 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 54.7% over 5 years.
CONS
- Trading 51.9% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 10.81M | 6.19M | 9.66M | 40.02M |
| Cost of Revenue | - | 5.69M | 3.99M | 6.08M | 6.34M |
| Gross Profit | - | 5.12M | 2.20M | 3.58M | 33.68M |
| Operating Expenses | - | 51.33M | 57.79M | 45.79M | 45.85M |
| Operating Income | - | -46.20M | -55.59M | -42.22M | -12.16M |
| EBITDA | - | -20.50M | -55.45M | -33.44M | -12.73M |
| Interest Expense | - | 323.00K | 586.00K | 502.00K | 315.00K |
| Pretax Income | - | -22.12M | -58.44M | -36.79M | -15.85M |
| Tax Provision | - | 0 | 127.00K | -56.00K | 1.00K |
| Net Income | - | -22.12M | -58.57M | -36.74M | -15.85M |
| Diluted EPS | - | -3.68 | -9.12 | -5.76 | -2.46 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 236.30M | 179.91M | 141.83M | 101.85M |
| Current Assets | - | 211.59M | 167.88M | 132.40M | 81.40M |
| Cash & Equivalents | - | 15.37M | 23.87M | 41.17M | 21.60M |
| Inventory | - | 14.25M | 23.69M | 23.09M | 6.59M |
| Receivables | - | 9.93M | 962.00K | 3.91M | 4.14M |
| Total Liabilities | - | 48.79M | 47.68M | 44.94M | 18.76M |
| Current Liabilities | - | 15.55M | 15.52M | 14.26M | 10.33M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 3.97M | 3.33M | 2.12M | 1.56M |
| Total Equity | - | 187.52M | 132.23M | 96.89M | 83.09M |
| Shares Outstanding | - | 6.24M | 6.25M | 6.27M | 6.50M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -27.52M | -49.66M | -41.46M | -32.88M |
| Investing Cash Flow | - | -124.55M | 56.71M | 58.58M | 13.85M |
| Financing Cash Flow | - | 50.97M | -1.14M | -1.56M | 4.00K |
| Capital Expenditure | - | -4.51M | -3.93M | -509.00K | -135.00K |
| Free Cash Flow | - | -32.03M | -53.59M | -41.97M | -33.01M |
| Net Change in Cash | - | -101.11M | 5.90M | 15.56M | -19.02M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 47.4% | 35.6% | 37.0% | 84.2% |
| Operating Margin % | - | -427.2% | -898.3% | -437.0% | -30.4% |
| Net Margin % | - | -204.5% | -946.5% | -380.3% | -39.6% |
| ROE % | - | -11.8% | -44.3% | -37.9% | -19.1% |
| ROCE % | - | -20.9% | -33.8% | -33.1% | -13.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PLSM
Pulsenmore Shares Soar After Joining Israel’s Healthcare AI Sandbox Programme (PLSM)
AI Programme Selection Sends Shares HigherPulsenmore Ltd. (NASDAQ:PLSM) shares surged 160% after the company announced it had been selected to participate in Israel’s Healthcare AI Regulatory Sandbox Program, an initiative led by the Israel…
Pulsenmore Selected for Israel Innovation Authority and Ministry of Health Program to Lead a $1 Million AI Development Project
Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in connected home ultrasound technology, today announced that it has been selected to participate in Israel's Healthcare AI Regulatory Sandbox Program, established by the Israel Innovat…
Pulsenmore Announces Pricing of $7.5 Million Private Placement with a Single Healthcare Focused Institutional Investor
Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced that it has entered into a securities purchase agreement with a healthcare-focused institutional investor, for the purchase and sale of 1,…
Why Did PLSM Stock Surge More Than 200% Today?
Pulsenmore’s home ultrasound platform will be used by Ouma Health, the largest maternity telemedicine company in the U.S.
Pulsenmore Announces Strategic Partnership with Ouma Health to Expand Access to Remote Prenatal Care Across the United States
Pulsenmore Ltd. (NASDAQ: PLSM) (TASE: PLSM), a pioneer in home ultrasound technology, today announced a strategic partnership with Ouma Health, a leading provider of virtual maternity care solutions in the United States.…
Pulsenmore Announces Full Year 2025 Financial Results and Webcast
Pulsenmore Announces Full Year 2025 Financial Results and Webcast
PLSM — Frequently Asked Questions
What is the current share price of PLSM?
As of 2026-08-05 17:25 PDT, PLSM trades at $3.54 on NASDAQ/NYSE. Its 52-week range is $3.28 to $7.36.
What is the market capitalisation of PLSM?
PLSM has a market capitalisation of $23.02M on NASDAQ/NYSE.
What is the P/E ratio of PLSM?
PLSM trades at a trailing price-to-earnings (P/E) ratio of -1.44. Its price-to-book (P/B) ratio is 0.28.
What is the return on equity (ROE) of PLSM?
PLSM has a return on equity (ROE) of -19.08%. Its return on capital employed (ROCE) is -13.29%.
Is PLSM a good stock to buy?
This page provides a data-driven analysis of PLSM, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.